Controversies in the diagnosis and treatment of periampullary tumours

Surg Oncol. 2022 Sep:44:101853. doi: 10.1016/j.suronc.2022.101853. Epub 2022 Sep 14.

Abstract

Most tumours in the head of the pancreas are adenocarcinomas of the exocrine pancreas. However, carcinomas located in the head of the pancreas may originate from the papilla of Vater, the distal part of the common bile duct, or the duodenum. Tumours of that region, within 2 cm of the greater duodenal papilla, have been usually described as periampullary neoplasms. Adenocarcinomas separated from the major duodenal papilla and located in the major pancreatic duct, common bile duct, or duodenum are identified as ductal pancreatic carcinomas, distal bile duct cholangiocarcinomas or duodenal carcinomas. Surgical treatment is the only chance for cure. Pancreatoduodenectomy is the procedure of choice. Regional lymphadenectomy and removal of at least 16 lymph nodes are necessary for optimal long-term outcomes. Indications for adjuvant chemotherapy remain controversial. This review evaluates the available data on the pathological assessment of periampullary tumours and discusses the controversies of therapeutic management, emphasising adjuvant treatment.

Keywords: Adjuvant chemotherapy; Ampullary tumours; Periampullary carcinoma.

Publication types

  • Review

MeSH terms

  • Adenocarcinoma* / pathology
  • Ampulla of Vater* / pathology
  • Carcinoma, Pancreatic Ductal* / pathology
  • Common Bile Duct Neoplasms* / diagnosis
  • Common Bile Duct Neoplasms* / surgery
  • Humans
  • Pancreatic Neoplasms* / diagnosis
  • Pancreatic Neoplasms* / pathology
  • Pancreatic Neoplasms* / therapy